| Literature DB >> 35607804 |
Bruno Pastene1,2, Ambroise Labarriere1, Alexandre Lopez1, Aude Charvet1, Aurélien Culver1, David Fiocchi1, Armand Cluzel3, Geoffrey Brioude3, Sharon Einav4, James Tankel5, Zeinab Hamidou6, Xavier Benoit D'Journo3, Pascal Thomas3, Marc Leone1,2, Laurent Zieleskiewicz1,2,7.
Abstract
BACKGROUND: Physiotherapy is a major cornerstone of enhanced rehabilitation after surgery (ERAS) and reduces the development of atelectasis after thoracic surgery. By initiating physiotherapy in the post-anaesthesia care unit (PACU), the aim was to evaluate whether the ultra-early initiation of rehabilitation (in the first hour following tracheal extubation) would improve the outcomes of patients undergoing elective thoracic surgery.Entities:
Mesh:
Year: 2022 PMID: 35607804 PMCID: PMC9127337 DOI: 10.1093/bjsopen/zrac063
Source DB: PubMed Journal: BJS Open ISSN: 2474-9842
Patients characteristics and demographics (paired analysis)
| Historical control group | Intervention group |
| ||
|---|---|---|---|---|
|
| 64 (56.0–71.0) | 64 (57–70.5) | 0.870 | |
|
| 25.2 (21.3–27.3) | 24.8 (21.1–27.3) | 0.240 | |
|
| WHO PS 0–1 | 454 (67.3) | 158 (70.2) | 0.420 |
| WHO PS > 1 | 221 (32.7) | 67 (29.8) | 0.420 | |
|
| ASA I–II | 454 (67.3) | 158 (70.2) | 0.460 |
| ASA > II | 221 (32.7) | 67 (29.8) | 0.460 | |
|
| 5 (4.0–7.0) | 6 (4.0–7.0) | 0.120 | |
|
| Hypertension | 209 (31.0) | 71 (31.6) | 0.870 |
| Heart failure | 11 (1.6) | 5 (2.2) | 0.560 | |
| Coronary disease | 79 (11.7) | 27 (12.0) | 0.910 | |
| COPD | 107 (15.9) | 38 (16.9) | 0.690 | |
| Oxygen therapy | 7 (1.0) | 1 (0.4) | 0.750 | |
| Malnutrition | 5 (0.7) | 1 (0.4) | 1 | |
| Tobacco use | 333 (49.3) | 153 (68.0) |
| |
|
| Stage 0 | 327 (48.4) | 136 (60.4) |
|
| Stage 1 | 205 (30.4) | 55 (24.4) | 0.106 | |
| Stage 2 | 117 (17.3) | 34 (15.1) | 0.472 | |
| Stage 3 | 21 (3.1) | 0 (0) |
| |
| Stage 4 | 3 (0.4) | 0 (0) | 0.577 | |
| Stage 5 | 2 (0.2) | 0 (0) | 1 | |
|
| Primitive lesion | 468 (69.3) | 146 (64.9) | 0.210 |
| Metastatic lesion | 108 (16.0) | 44 (29.6) | 0.219 | |
| Benign lesion | 17 (2.5) | 10 (4.4) | 0.174 | |
| Infectious/inflammatory | 66 (9.8) | 22 (9.8) | 1 | |
| Congenital | 6 (0.9) | 0 (0) | 0.346 | |
| Degenerative | 10 (1.5) | 3 (1.3) | 1 | |
|
| 127 (80.0–160.0) | 123 (81.0–162.0) | 0.420 | |
|
| Single shot paravertebral block | 438 (64.9) | 155 (68.9) | 0.290 |
| Peridural analgesia | 87 (12.9) | 34 (15.1) | 0.430 | |
| Paravertebral catheter | 146 (21.6) | 35 (15.6) | 0.055 | |
| Not found | 4 (0.6) | 1 (0.4) | ||
|
| Lobectomy | 437 (64.8) | 137 (60.9) | 0.300 |
| Bi lobectomy | 10 (1.5) | 4 (1.8) | 0.760 | |
| Segmentectomy | 78 (11.6) | 34 (15.1) | 0.160 | |
| Unique partial resection | 117 (17.3) | 44 (19.6) | 0.480 | |
| Multiple partial resections | 33 (4.9) | 6 (2.7) | 0.190 | |
|
| Invasive | 126 (18.7) | 42 (18.7) | 1 |
| Minimally invasive | 549 (81.3) | 183 (81.3) | 1 | |
Bold values indicate P < 0.005. i.q.r., interquartile range; WHO PS, WHO physical score; mMRC: modified Medical Research Council. Values are n (%) unless stated otherwise.
Comparison of outcomes between historical control and intervention groups (paired analysis)
| Historical control group ( | Intervention group ( |
| |
|---|---|---|---|
|
| 77 (11.4) | 15 (6.7) |
|
|
| 131 (19.4) | 31 (13.7) | 0.058 |
|
| 6 (4.0–9.0) | 5 (4.0–7.0) |
|
|
| 48 (7.1) | 19 (8.4) | 0.460 |
|
| 8 (1.2) | 3 (1.3) | 1 |
|
| 0 (0–8.7) | 0 (0–8.7) | 0.080 |
|
| 39 (5.8) | 6 (2.7) | 0.076 |
|
| 21 (3.1) | 1 (0.4) |
|
|
| 23 (3.4) | 7 (3.1) | 1 |
|
| 58 (8.6) | 19 (8.4) | 1 |
|
| 20 (3.0) | 9 (4.0) | 0.510 |
|
| 41 (6.1) | 21 (9.3) | 0.230 |
|
| 9 (1.3) | 1 (0.4) | 0.470 |
Bold values indicate P < 0.005. i.q.r., interquartile range. Values are n (%) unless stated otherwise.
Comparison of outcomes between contemporary control and intervention groups (unpaired analysis)
| Contemporary control group ( | Intervention group ( |
| |
|---|---|---|---|
|
| 46 (16.4) | 16 (6.6) |
|
|
| 82 (29.2) | 33 (13.6) |
|
|
| 6 (4.0–10.0) | 5 (4.0–7.0) |
|
|
| 21 (7.5) | 20 (8.2) | 0.748 |
|
| 6 (2.1) | 3 (1.2) | 0.429 |
|
| 0 (0-20.9) | 0 (0–8.7) |
|
|
| 21 (7.5) | 8 (3.3) |
|
|
| 13 (4.6) | 2 (0.8) |
|
|
| 14 (5.0) | 7 (2.9) | 0.221 |
|
| 45 (16.0) | 20 (8.2) |
|
|
| 18 (6.4) | 10 (4.1) | 0.245 |
|
| 37 (13.2) | 22 (9.1) | 0.137 |
|
| 5 (1.8) | 1 (0.4) | 0.142 |
Bold values indicate P < 0.005. i.q.r., interquartile range. Values are n (%) unless stated otherwise.
Comparison of outcomes between non-ambulatory and ambulatory subgroups
| Non-ambulatory intervention subgroup ( | Ambulatory subgroup (n = 138) |
| |
|---|---|---|---|
|
| 10 (9.5) | 3 (2.2) |
|
|
| 24 (22.9) | 29 (21.0) | 0.730 |
|
| 6 (4.0–7.0) | 5 (4.0–7.0) |
|
|
| 0 (0) | 0 (0) | 1 |
|
| 2 (1.9) | 2 (1.5) | 0.782 |
|
| 0 (0–20.9) | 0 (0-0) | 0.195 |
|
| 5 (4.8) | 3 (2.2) | 0.263 |
|
| 2 (1.9) | 0 (0) | 0.109 |
|
| 1(1.0) | 6 (4.3) | 0.117 |
|
| 8 (7.6) | 12 (8.6) | 0.762 |
|
| 5 (4.8) | 5 (3.6) | 0.658 |
|
| 5 (4.8) | 17 (12.3) | 0.042 |
|
| 0 (0) | 1 (0.7) | 0.382 |
Bold values indicate P < 0.005. i.q.r., interquartile range. Values are n (%) unless stated otherwise.